Speranza Therapeutics distributes and clinically supports orphan drugs and medical devices, creating options for patients whose chronic illnesses are not being effectively addressed.
Our guiding principle is simple - To remove the inherent challenges in delivering treatment to patients in need through proven, clinically effective therapeutics and technology.
S.T. Genesis™ is the first Speranza Therapeutics Innovation to hit the market. S.T. Genesis is an FDA-cleared Percutaneous Nerve Field Stimulator (PNFS), used as an aid to reduce the symptoms of opioid withdrawal. This powerful solution to the opioid crisis will partner with treatment centers, providing them with leading clinical technology, comprehensive protocols, patient support, and reimbursement services.
To learn more about Speranza Therapeutics and our products, please visit our website: http://speranzatherapeutics.com/
Company Details
- Employees
- 13
- Founded
- -
- Address
- 433 Plaza Real,
- Phone
- (844) 477-3726
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- speranzatherapeutics.com
- HQ
- Boca Raton, FL
Speranza Therapeutics Questions
Speranza Therapeutics's helpline number is (844) 477-3726
Speranza Therapeutics's website is speranzatherapeutics.com
Speranza Therapeutics's LinkedIn profile is https://www.linkedin.com/company/speranza-therapeutics
Speranza Therapeutics has
13 employees.
View email and phone details for 13
employees at Speranza Therapeutics.
Speranza Therapeutics's industry is
Biotechnology Research
Speranza Therapeutics's top competitors are
The Hire Calling Foundation,
Baymark Health Services,
Melrose Consulting,
Speranza,
Biomatrix Specialty Infusion Pharmacy,
Pinnacle Treatment Centers, Inc.,
Huml Health,
Hygea Healthcare,
Wellness Team,
Aware Recovery Care, Inc..
Speranza Therapeutics's support email address is info@speranzatherapeutics.com
Speranza Therapeutics's categories are Biotechnology Research
Speranza Therapeutics's founding year is 2020
